AAM Statement on U.S. Court of Appeals Ruling on Maryland HB 631

WASHINGTON, DC (April 13, 2018) — Today, the United States Court of Appeals for the Fourth Circuit ruled that Maryland’s HB 631 is unconstitutional because it violates the Commerce Clause of the U.S. Constitution. As AAM has always maintained, this law, and any others modeled from it, would harm patients because the law would reduce generic drug competition and choice, thus resulting in an overall increase in drug costs due to increased reliance upon more-costly branded medications.

Chester "Chip" Davis, Jr. President and CEO, Association for Accessible Medicines

Read the Court Ruling

View the AAM Action Center and tell your lawmaker to oppose bills that harm patient access to affordable generic medicines!


Media Inquiries:
Rachel Schwartz
202.249.7147 (o)
202.251.8881 (c)

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.